Literature DB >> 30664174

MicroRNA‑601 serves as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3.

Yanan Song1, Saifei He1, Juhua Zhuang1, Guoyu Wang1, Jing Ni1, Suiliang Zhang2, Ying Ye1, Wei Xia1.   

Abstract

Recently, microRNAs (miRNAs) have been acknowledged as important regulators of hepatocarcinogenesis and tumor progression. Therefore, identifying the underlying molecular mechanisms of miRNAs in the occurrence and development of hepatocellular carcinoma (HCC) may be important for understanding the pathogenesis of HCC and aid the identification of potential therapeutic strategies. In the present study, miRNA (miR)‑601 was significantly downregulated in HCC tissues and cell lines; low miR‑601 expression was strongly associated with tumor, node and metastasis staging and lymph node metastasis of patients with HCC. In addition, the overexpression of miR‑601 expression significantly inhibited the proliferation and invasion of HCC cells. Regarding the underlying mechanism, phosphoinositide‑3‑kinase regulatory subunit 3 (PIK3R3) was predicted to be a direct target of miR‑601 in HCC cells. Furthermore, restoration of PIK3R3 expression in these cells counteracted the inhibitory effects of miR‑601 on cell proliferation and invasion in HCC. Notably, miR‑601 overexpression inhibited the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway in HCC via the regulation of PIK3R3. Collectively, these results demonstrated that miR‑601 may inhibit the progression of HCC by directly targeting PIK3R3 and regulating the AKT/mTOR signaling pathway. Therefore, miR‑601 may be an effective therapeutic target for the treatment of patients with HCC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30664174     DOI: 10.3892/mmr.2019.9857

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Long noncoding RNA HOTAIR promotes breast cancer development by targeting ZEB1 via sponging miR-601.

Authors:  Yuanyuan Wang; Guoliang Gong; Jingyun Xu; Yuanxin Zhang; Shenggui Wu; Shaohong Wang
Journal:  Cancer Cell Int       Date:  2020-07-17       Impact factor: 5.722

2.  Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway.

Authors:  QianZhi Ni; Zhenhua Chen; Qianwen Zheng; Dong Xie; Jing-Jing Li; Shuqun Cheng; Xingyuan Ma
Journal:  Cancer Sci       Date:  2020-03-10       Impact factor: 6.716

3.  Circular RNA hsa_circ_0061395 accelerates hepatocellular carcinoma progression via regulation of the miR-877-5p/PIK3R3 axis.

Authors:  Yanhui Yu; Lijuan Bian; Renfei Liu; Yitong Wang; Xia Xiao
Journal:  Cancer Cell Int       Date:  2021-01-06       Impact factor: 5.722

4.  Expression of miRNA-601 and PD-L1 among Iranian Patients with Lung Cancer and Their Relationship with Smoking and Mycoplasma Infection.

Authors:  Mahla Ganjali; Babak Kheirkhah; Kumarss Amini
Journal:  Cell J       Date:  2021-12-29       Impact factor: 2.479

Review 5.  Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway.

Authors:  Mengnan Guo; Ning Li; Jianxia Zheng; Wei Wang; Yan Wu; Xu Han; Jiapei Guo; Weixi Chen; Zekun Bai; Wen Bai; Jinghua Wu
Journal:  Can J Gastroenterol Hepatol       Date:  2021-05-25

6.  MiR-513b-5p represses autophagy during the malignant progression of hepatocellular carcinoma by targeting PIK3R3.

Authors:  Wei Jin; Yilei Liang; Shuyou Li; Guoxiang Lin; Haiying Liang; Zhenni Zhang; Weiming Zhang; Rongjun Nie
Journal:  Aging (Albany NY)       Date:  2021-06-13       Impact factor: 5.682

7.  Long noncoding RNA PP7080 promotes hepatocellular carcinoma development by sponging mir-601 and targeting SIRT1.

Authors:  Weifang Song; Zhang Wenhui; Yao Ruiqiang; Xinli Hu; Ting Shi; Meijiao Wang; Haijuan Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.